Heron Therapeutics Inc · Cash & Short-Term Investments

Latest reported$46.63Mperiod endingDec 31, 2025

HRTX FY Cash & Short-Term Investments ($15.90M → $46.63M)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

HRTX cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	46,631,000
Dec 31, 2024	59,283,000
Dec 31, 2023	80,409,000
Dec 31, 2022	84,852,000
Dec 31, 2021	157,580,000
Dec 31, 2020	208,491,000
Dec 31, 2019	390,972,000
Dec 31, 2018	332,371,000
Dec 31, 2017	172,379,000
Dec 31, 2016	51,138,000
Dec 31, 2015	131,166,000
Dec 31, 2014	72,675,000
Dec 31, 2013	72,287,000
Dec 31, 2012	53,506,000
Dec 31, 2011	17,974,000
Dec 31, 2010	2,109,000
Dec 31, 2009	7,593,000
Dec 31, 2008	10,538,000
Dec 31, 2007	35,062,000
Dec 31, 2006	15,522,000
Dec 31, 2005	5,809,000
Dec 31, 2004	13,596,000
Dec 31, 2003	9,484,000
Dec 31, 2002	14,121,000
Dec 31, 2001	19,494,372
Dec 31, 2000	22,522,656
Dec 31, 1999	3,700,000
Dec 31, 1998	4,100,000
Dec 31, 1997	8,700,000
Dec 31, 1996	5,400,000
Dec 31, 1995	5,200,000
Dec 31, 1994	2,700,000
Dec 31, 1993	1,800,000
Dec 31, 1992	2,700,000
Dec 31, 1991	1,600,000
Dec 31, 1990	1,700,000
Dec 31, 1989	2,600,000
Dec 31, 1988	11,400,000
Dec 31, 1987	15,900,000